Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor.
about
Elevated expression of AKR1C3 increases resistance of cancer cells to ionizing radiation via modulation of oxidative stressDifferential expression of type 2 3α/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) in tumors of the central nervous system.Suppressed expression of type 2 3alpha/type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) in endometrial hyperplasia and carcinoma.Aldo-keto reductase 1C3 is overexpressed in skin squamous cell carcinoma (SCC) and affects SCC growth via prostaglandin metabolism.Aberrantly Expressed Genes in HaCaT Keratinocytes Chronically Exposed to Arsenic Trioxide.Aldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinoma.Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.Expression of aldo-keto reductase family 1 member C3 (AKR1C3) in neuroendocrine tumors & adenocarcinomas of pancreas, gastrointestinal tract, and lung.Identification of genes associated with castration‑resistant prostate cancer by gene expression profile analysis.Simvastatin in combination with meclofenamic acid inhibits the proliferation and migration of human prostate cancer PC-3 cells via an AKR1C3 mechanism.Methyl jasmonate enhances the radiation sensitivity of esophageal carcinoma cells by inhibiting the 11-ketoprostaglandin reductase activity of
P2860
Q28545132-72841FC3-3C0C-4233-8B0E-CE2FA1D1A256Q30478225-A74F37F7-62D4-4C30-BA8D-65BEB5CD68C0Q34007469-BA07B6E1-F8B4-4436-8A99-4F0AE3AD6AB1Q34016727-AEFE3BC4-4B3F-4FCC-BE55-017CC63F9A12Q34727862-1AA78D48-7427-45ED-AD4A-192E6A34E0C8Q36003283-7CA688DD-0714-4D8F-8013-11F253CB9363Q36200428-F2A1CB94-DF89-4D0B-8624-730FEF8AF619Q37277775-DF777E31-98D1-4A55-A3F5-509E17CAAE81Q47811759-281951B0-1799-4DB8-B374-750164D80C12Q50053255-FBCADCF1-7373-415F-AF5E-B109722E3539Q58781589-80EE45AC-2B4F-4759-A9D2-D360F4226A77
P2860
Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumor.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Expression of AKR1C3 in renal ...... l carcinoma, and Wilms' tumor.
@ast
Expression of AKR1C3 in renal ...... l carcinoma, and Wilms' tumor.
@en
type
label
Expression of AKR1C3 in renal ...... l carcinoma, and Wilms' tumor.
@ast
Expression of AKR1C3 in renal ...... l carcinoma, and Wilms' tumor.
@en
prefLabel
Expression of AKR1C3 in renal ...... l carcinoma, and Wilms' tumor.
@ast
Expression of AKR1C3 in renal ...... l carcinoma, and Wilms' tumor.
@en
P2093
P2860
P1476
Expression of AKR1C3 in renal ...... l carcinoma, and Wilms' tumor.
@en
P2093
Awet Gherezghiher
Bradley P Kropp
Daniel J Culkin
Hsueh-Kung Lin
Joseph T Azzarello
Kar-Ming Fung
Trevor M Penning
Vladislav Zakharov
Zhongxin Yu
P2860
P304
P577
2009-11-15T00:00:00Z